Skip to content

Gradual change in methacholine bronchial hyperresponsiveness in bronchial asthma patient population

Gradual change in methacholine bronchial hyperresponsiveness in bronchial asthma patient population - Gradual change in methacholine bronchial hyperresponsiveness

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000019257
Enrollment
200
Registered
2015-10-07
Start date
2015-10-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma

Interventions

None listed

Sponsors

Department of Respiratory Medicine, Fujita Health University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with bronchial asthma Bronchial asthma patients who underwent the first methacholine airway hyperresponsiveness test

Exclusion criteria

Exclusion criteria: Patients with apparent infection

Design outcomes

Primary

MeasureTime frame
gradual change of methacholinPC-20(provocative concentration that results in a 20% fall in FEV1) in first methacholine hyperresponsiveness test

Secondary

MeasureTime frame
asthma medications, bronchial asthma severity before methacholine hyperresponsiveness test

Countries

Japan

Contacts

Public ContactIsogai Sumito

Fujita Health University of Medicine Department of Respiratory Medicine

hirosimax2000@yahoo.co.jp0562-93-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026